• Non ci sono risultati.

MDCT of the Pancreas II.3

N/A
N/A
Protected

Academic year: 2021

Condividi "MDCT of the Pancreas II.3"

Copied!
5
0
0

Testo completo

(1)

Introduction

With multidetector-row computed tomography (MDCT), images of the pancreas can be acquired with less than 1-mm collimation and viewed with reconstructed slice thickness ranging from 1 to 5 mm. Thus images are reconstructed from isotropic or nearly isotropic voxels, depending up- on the specific acquisition parameters used. This technique enables very high-quality three-dimen- sional, multiplanar and curved planar reconstruc- tions to be acquired. Consequently, large CT data sets can be viewed efficiently as volumes, rather than as individual transverse slices. The ability to view the image data as a volume also makes it eas- ier to communicate the results efficiently to refer- ring physicians, using a limited number of selected volume-rendered or multiplanar images. These images can be reconstructed to demonstrate the pancreatic duct, bile ducts, and peripancreatic ves- sels in a clinically relevant fashion.

MDCT Technique

Prior to imaging, patients drink approximately 1 l of fluid to opacify the stomach, duodenum, and jejunum. Water is preferred, rather than iodine or barium-based positive contrast materials, to avoid interference with volume-rendered reconstruc- tions of the peripancreatic vessels. For the detec- tion or staging of pancreatic adenocarcinoma, a volume of 150 ml of low-osmolar contrast materi- al is administered at a rate of 5 ml/s [1, 2]. Images are acquired in two phases: a pancreatic parenchy- mal phase (beginning at 40–45 s from the start of contrast medium injection) and a venous or hepat- ic parenchymal phase (beginning 70 s from the start of contrast medium injection) [3, 4]. The pan- creatic phase images are acquired with less than 1 mm collimation, whereas the venous phase im-

ages are acquired with 1.5-mm or 2.5-mm collima- tion, depending upon whether 4-detector or 16-de- tector CT is used (Tables 1 and 2). The images are reconstructed with 3-mm slice thickness at 2-mm intervals (1-mm slice thinkness at 1-mm intervals for 3D reconstructions). The data can be viewed on a workstation where three-dimensional vol- ume-rendered, maximum intensity projection and multiplanar images can be viewed [5-9]. In addi- tion, curved planar images can be constructed through key anatomical structures, such as the peripancreatic arteries and veins, the common bile duct, and the pancreatic duct [10, 11] (Figs. 1–5).

Adenocarcinoma of the Pancreas

MDCT is established as the primary initial imag- ing method for both the detection and staging of suspected pancreatic carcinoma. Most studies have found that CT is highly reliable when it demon- strates features indicating that a tumor is unre- sectable [12, 13]. The positive predictive value of a diagnosis of unresectability with single-detector helical CT (SDCT) has ranged from 92% to 100%

[14, 18]. SDCT is less reliable, however, for predict- ing whether a tumor is resectable [negative predic- tive value (NPV) 76%–90%] [14–19]. In a recent study using eight-detector MDCT, the NPV and ac- curacy for vascular invasion were 100% and 99%, respectively [20]. The overall NPV in this study, however, was 87% due to undetected small hepatic and peritoneal metastases, which continue to be a limitation of CT, even MDCT.

Although criteria for unresectability vary among surgeons, imaging features that generally indicate unresectability include vascular invasion, lymph node metastases beyond those in the im- mediate vicinity of the pancreas, and distant metastases. Metastases most commonly involve the liver or peritoneum.

II.3

MDCT of the Pancreas

Jay P. Heiken

(2)

Recent studies have demonstrated the useful- ness of CT for evaluating vascular invasion by pan- creatic carcinomas [20-24]. When a pancreatic tu- mor is not contiguous with a critical peripancreat- ic vessel such as the hepatic artery, superior mesen- teric artery, superior mesenteric vein, or portal vein (i.e., when an intervening fat plane is present), vas-

cular invasion is almost never present. When the tumor is contiguous with less than one-quarter of the vessel circumference, it is resectable in the ma- jority of cases, but when the tumor is contiguous with one-quarter to one-half of the vessel circum- ference, it is unresectable in the majority of cases. It is in the group of patients in which the tumor con-

a b c

Fig. 1a-c.Unresectable pancreatic cancer. a The transaxial image demonstrates a large heterogeneous mass (m) involving the tail of the pancreas. The posterior superior pancreatoduodenal vein (yellow arrow) and the gastroepiploic vein (white arrow) are dilated, indicating invasion of the superior mesenteric vein and splenic vein, respectively. b A coronal maximum intensity projection image shows the dilat- ed posterior superior pancreaticoduodenal vein (black arrow) and gastroepiploic vein (yellow arrows). The portal vein is occluded at its con- fluence with the superior mesenteric vein (white arrow). c A transaxial maximum intensity projection image also demonstrates the dilat- ed posterior superior pancreaticoduodenal (white arrow) and gastroepiploic (yellow arrows) veins

Table 1. 4-row MDCT Pancreas: Dual Phase

Indications Evaluation of known or suspected pancreatic neoplasms Evaluation for complications of pancreatitis

Scan range Pre-contrast: Standard abdomen

Arterial: (craniocaudal) from third duodenum or inferior tip of liver, whichever is more caudal to the top of the pancreas.

For suspected islet cell tumors, scan up to the diaphragm Venous: (craniocaudal) from iliac crest to diaphragm mA selection 180-250 mA-adjust for patient size

Detector collimation Pre-contrast: 2.5 mm Arterial: 1 mm

Venous: 2.5 mm

Rotation time 0.5 s

Table speed (pitch) Pre-contrast: 10–18 mm/rot (1-1.75) Arterial: 4–7 mm/rot (1-1.75) Venous: 13–18 mm/rot (1-1.75)

Slice thickness Pre-contrast 5 mm

Arterial: 3 mm and 1.25 mm (3-D)

Venous: 3 mm

Reconstruction int. 3 mm for the 5-mm slices 1 mm for the 1.25-mm slices

IV contrast type 350–370 mgI/ml

Volume: 150 ml Injection rate: 5 ml/s

Scan delay Arterial: 40 s (for suspected islet cell tumors, this should be decreased to 30 s) Venous: 60 s (or ASAP)

(3)

tacts up to one-half of the vessel circumference that endoscopic ultrasonography may be of value in as- sessing vascular invasion. Otherwise, surgical ex- ploration is needed to determine resectability. Tu- mors contacting more than one-half of the circum- ference of the vessel are nearly always unresectable.

Another sign of unresectability of adenocarcinoma

of the head of the pancreas is a teardrop shape of the superior mesenteric vein, which represents ei- ther direct tumor infiltration of the vein or peritu- moral fibrosis adherent to the vessel [25].

Assessment of the peripancreatic veins can also provide information regarding the likelihood of vascular invasion by pancreatic carcinoma. In pa- Table 2. 16-row MDCT

Pancreas: Dual Phase

Indications Evaluation of known or suspected pancreatic neoplasms Evaluation for complications of pancreatitis

Scan range Pre-contrast: standard abdomen

Arterial: (craniocaudal) from diaphragm to bottom of liver Venous: (craniocaudal) from diaphragm to iliac crest

Effective mA 180

Detector collimation Pre-contrast: 1.5 mm Arterial: 0.75 mm Venous: 1.5 mm

Rotation time 0.5 s

Table speed (pitch) Pre-contrast: 24–30 mm/rot (1–1.25) Arterial: 12–15 mm/rot (1–1.25) Venous: 24–30 mm/rot (1–1.25)

Slice thickness Pre-contrast 5 mm

Arterial: 3 mm and 1 mm (3-D)

Venous: 3 mm

Reconstruction int. 3 mm for the 5-mm slices 0.8 mm for the 1-mm slices

IV contrast type 350–370 mgI/ml

Volume: 150 ml Injection rate: 5 ml/s

Scan delay Arterial: 45 s (for suspected islet cell tumors, this should be decreased to 35 s) Venous: 65 s (or ASAP)

Fig. 2.Resectable pancreatic cancer. Curved planar reformation through the pancreatic duct demonstrates a mass (m) in the body of the pancreas. The tail of the pancreas is atrophic with a dilated pancreatic duct (yellow arrows). The pancreatic duct in the head and neck of the pancreas (white arrow) is normal

Fig. 3.Pancreatic adenocarcinoma. Curved planar reformatted image through the common bile duct (white arrow) and pancreat- ic duct (black arrow) shows obstruction of both ducts by an adeno- carcinoma that diffusely infiltrates the pancreatic head

(4)

tients with pancreatic carcinoma, dilatation of the posterior superior pancreaticoduodenal vein or the gastrocolic trunk is a sign of portal or superior mesenteric vein invasion [26-29] (Fig. 1). However, a dilated gastrocolic trunk should not be used as an independent sign of surgical unresectability [24].

Pancreatitis

MDCT is the imaging method of choice for evalu- ating complications of acute and chronic pancre- atitis. Three-dimensional, multiplanar, and curved planar reconstructions of the data are useful for demonstrating the extent of pancreatic necrosis (Fig. 5) and peripancreatic fluid collections, and for demonstrating intraductal pancreatic calculi.

CT angiography is an excellent technique for de- lineating pseudoaneurysms of the peripancreatic vessels.

References

1. Tublin ME, Tessler FN, Cheng SL et al (1999) Effect of injection rate of contrast medium on pancreatic and hepatic helical CT. Radiology 210:97-101 2. Kim T, Murakami T, Takahashi S et al (1999) Pan-

creatic CT imaging: effects of different injection rates and doses of contrast material. Radiology 212:219-225

3. Lu DS, Vandantham S, Krasny RM et al (1996) Two- phase helical CT for pancreatic tumors: pancreatic versus hepatic phase enhancement of tumor, pan- creas, and vascular structures. Radiology 199:697- 4. Boland GW, O’Malley ME, Saez M et al (1999) Pan-701 creatic-phase versus portal vein-phase helical CT of the pancreas: optimal temporal window for evalua- tion of pancreatic adenocarcinoma. AJR Am J Roentgenol 172:605-608

5. Raptopoulos V, Steer ML, Sheiman RG et al (1997) The use of helical CT and CT angiography to predict vascular involvement from pancreatic cancer: corre-

lation with findings at surgery. AJR Am J Roentgenol 168:971-977

6. Baek SY, Sheafor DH, Keogan MT (2001) Two-di- mensional multiplanar and three-dimensional vol- ume-rendered vascular CT in pancreatic carcinoma:

interobserver agreement and comparison with stan- dard helical techniques. AJR Am J Roentgenol 176:1467-1473

7. Fishman EK, Horton KM, Urban BA (2000) Multide- tector CT angiography in the evaluation of pancre- atic carcinoma: preliminary observations. J Comput Assist Tomogr 24:849-853

8. Lepanto L, Arzoumanian Y, Glanfelice D et al (2002) Helical CT with CT angiography assessing peri- ampulary neoplasms: identification of vascular in- vasion. Radiology 222:347-352

9. Nino-Murcia M, Tamm EP, Charnsangavej C et al (2003) Multidetector-row helical CT and advanced postprocessing techniques for the evaluation of pancreatic neoplasms. Abdom Imaging 28:366-377 10. Nino-Murcia M, Jeffrey RB, Beaulieu CF et al (2001)

Multidetector CT of the pancreas and bile duct sys- tem: value of curved planar reformations. AJR Am J Roentgenol 176:689-693

11. Prokesch RW, Chow L, Beaulieu CF et al (2002) Lo- cal staging of pancreatic carcinoma with multide- tector-row CT: use of curved planar reformation–

initial experience. Radiology 224:764-768

12. Andrén-Sandberg A, Lindberg CG, Lundstedt C et al (1998) Computed tomography and laparoscopy in the assessment of the patient with pancreatic can- cer. J Am Coll Surg 186:35-40

13. Freeny PC, Traverso LW, Ryan JA (1993) Diagnosis and staging of pancreatic adenocarcinoma with dy- namic computed tomography. Am J Surg 165:600-605 14. Zeman RK, Cooper C, Zeiberg AS et al (1997) TNM staging of pancreatic carcinoma using helical CT.

AJR Am J Roentgenol 169:459-464

15. Diehl SJ, Lehmann KJ, Sadick M et al (1998) Pancre- atic cancer: value of dual-phase helical CT in assess- ing resectability. Radiology 206:373-378

16. Sheridan MB, Ward J, Guthrie JA et al (1999) Dy- namic contrast-enhanced MR imaging and dual- phase helical CT in the preoperative assessment of suspected pancreatic cancer: a comparative study with receiver operating characteristic analysis. AJR Am J Roentgenol 173:583-590

17. Legmann P, Vignaux O, Dousset B et al (1998) Pan- creatic tumors: comparison of dual-phase helical CT Fig. 4.Unresectable pancreatic carcinoma. Curved planar refor-

mation through the hepatic artery (arrow) demonstrates that the vessel is encased by tumor

Fig. 5.Pancreatic necrosis in a patient with severe acute pancre- atitis. Curved planar reformatted image through the pancreas shows necrosis of the pancreatic head and neck (arrow; D duode- num, P intact pancreatic parenchyma)

(5)

and endoscopic sonography. AJR Am J Roentgenol 170:1315-1322

18. Coley SC, Strickland NH, Walker JD et al (1997) Spi- ral CT and the pre-operative assessment of pancre- atic adenocarcinoma. Clin Radiol 52:24-30

19. Tabuchi T, Itoh K, Ohshio G et al (1999) Tumor staging of pancreatic adenocarcinoma using early and late-phase helical CT. AJR Am J Roentgenol 173:375-380

20. Vargas R, Nino-Murcia M. Trueblood W, Jeffrey RB (2004) MDCT in pancreatic adenocarcinoma: pre- diction of vascular invasion and resectability using a multiphasic technique with curved planar reforma- tions. AJR Am J Roentgenol 182:419-425

21. Loyer EM, David CL, Dubrow RA et al (1996) Vas- cular involvement in pancreatic adenocarcinoma:

reassessment by thin-section CT. Abdom Imaging 21:202-206

22. Lu DSK, Reber HA, Krasny RM et al (1997) Local staging of pancreatic cancer: criteria for unre- sectability of major vessels as revealed by pancreat- ic-phase, thin-section helical CT. AJR Am J Roentgenol 168:1439-1443

23. Furukawa H, Kosuge T, Mukai K et al (1998) Helical computed tomography in the diagnosis of portal vein invasion by pancreatic head carcinoma. Arch Surg 133:61-65

24. O’Malley ME, Boland GWL, Wood BJ et al (1999) Adenocarcinoma of the head of the pancreas: deter- mination of surgical unresectability with thin-sec- tion pancreatic-phase helical CT. AJR Am J Roentgenol 173:1513-1518

25. Hough TJ, Raptopoulos V, Siewert B et al (1999) Teardrop superior mesenteric vein: CT sign for un- resectable carcinoma of the pancreas. AJR Am J Roentgenol 173:1509-1512

26. Mori H, Miyake H, Aikawa H et al (1991) Dilated posterior superior pancreaticoduodenal vein: recog- nition with CT and clinical significance in patients with pancreaticobiliary carcinomas. Radiology 181:793-800

27. Mori H, McGrath FP, Malone DE et al (1992) The gastrocolic trunk and its tributaries: CT evaluation.

Radiology 182:871-877

28. Hommeyer SC, Freeny PC, Crabo LG (1995) Carci- noma of the head of the pancreas: evaluation of the pancreaticoduodenal veins with dynamic CT–po- tential for improved accuracy in staging. Radiology 196:233-238

29. Yamada Y, Mori H, Kiyosue H et al (2000) CT as- sessment of the inferior peripancreatic veins: clini- cal significance. AJR Am J Roentgenol 174:677-684

Riferimenti

Documenti correlati

It comes with a Java-based implementation providing coordination as a service [96] in the form of a Java library providing API and a middleware runtime, especially targeting

Il progetto botanico deve individuare, a seguito delle analisi floristi- che e vegetazionali e delle elaborazioni effettuate (bioindicazione e serie dinamica della vegetazione),

Patients presenting with low preoperative risk of CBDS (486 cases) were candidate to LC with routine cysticotomy and bile flushing: 121 patients among them presented thick bile

It was found how solution 5_16 produces the minimum total pressure losses coefficient, hence the best value of the first objective

A search of the Medline/PubMed (National Library of Medicine, Bethesda, Maryland) was performed using a single or combination of key words including imaging, ultrasonography,

Projective image ( c ) showing severe narrowing of the proximal common hepatic bile duct (arrow) with secondary intrahepatic bile duct dilatation.. #90 Bile Duct Involvement

ERCP image shows a central stricture in the common hepatic duct (arrow) and diffuse ischemic changes in the intrahepatic ducts... The irregular or shaggy appearance of the bile

We study in detail the analytic properties of the Thermodynamic Bethe Ansatz (TBA) equations for the anomalous dimensions of composite operators in the planar limit of the 3D N =